High affinity human antibodies to pcsk9

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/40 (2006.01) A61K 39/395 (2006.01) A61P 3/06 (2006.01) C12N 9/64 (2006.01)

Patent

CA 2747123

An human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human proprotein convertase subtilisin/kexin type 9 (hPCSK9) characterized by the ability to reduce serum LDL cholesterol by 40-80% over a 24, 60 or 90 day period relative to predose levels, with little or no reduction in serum HDL cholesterol and/or with little or no measurable effect on liver function, as determined by ALT and AST measurements.

L'invention porte sur un anticorps humain ou sur un fragment de liaison à un antigène d'un anticorps humain qui se lie et inhibe spécifiquement la proprotéine convertase humaine subtilisine/kexine de type 9 (hPCSK9) qui est caractérisée par l'aptitude à réduire le cholestérol LDL dans le sérum de 40-80 % sur une période de 24, 60 ou 90 jours par rapport aux taux d'avant la dose, avec peu ou pas de réduction du cholestérol HDL dans le sérum et/ou peu ou pas d'effet mesurable sur la fonction du foie, tel que déterminé par des mesures ALT et AST.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

High affinity human antibodies to pcsk9 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High affinity human antibodies to pcsk9, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High affinity human antibodies to pcsk9 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2074491

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.